2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Accelerant Holdings signed a merger agreement on August 13, 2026, under which Merger Sub will merge into the company and it will become a wholly owned subsidiary of Cherry Tree BidCo, an affiliate of Thoma Bravo Discover Fund V, L.P. Shareholders would receive $20.25 in cash per share, plus a possible ticking amount, and the Class A shares would be delisted from the New York Stock Exchange if the merger closes.
Merger consideration is $20.25 in cash per share, plus a possible ticking amount of $0.00333 per share for each calendar day after the Ticking Amount Start Date
Go-shop period runs until 11:59 p.m. Eastern on September 22, 2026, after which no-shop restrictions apply
Closing requires approval by at least two-thirds of votes cast by shareholders entitled to vote, HSR clearance, and specified insurance regulatory approvals; the financing is not a closing condition
Merger must close by August 13, 2027, with an automatic extension to November 13, 2027 in certain circumstances
Dominari Holdings entered inducement agreements on August 13, 2026, with holders of Series A warrants covering up to 3,124,690 shares, offering a reduced $2.20 cash exercise price or a 5:1 share exchange. The company expects about $2.9 million in gross proceeds from cash exercises and about 115,000 new shares from exchanges, and about 1.2 million Series A warrants would remain outstanding, which the company says reduces market overhang.
Existing Series A warrants, issued February 14, 2025, had an original exercise price of $3.72 per share.
Option A: cash exercise at $2.20 per share on or before 4 p.m. ET on September 11, 2026.
Option B: exchange at 5:1, with one new share issued for every five underlying shares, for no additional consideration.
Company expects about $2.9 million in gross proceeds and about 115,000 shares issued under the options.
On August 13, 2026, Eikon Therapeutics furnished an updated corporate presentation as Exhibit 99.1 to a Form 8-K under Regulation FD. The deck restates clinical data and pipeline timelines, including 2H 2026 Phase 2 data readouts for EIK1001 and an IND submission for EIK1006 projected by the end of 2026. The filing contains no financial results, guidance, or transaction terms.
Updated corporate presentation, labeled Q3 Company Update August 2026, furnished as Exhibit 99.1 and not deemed filed under the Exchange Act.
EIK1001 TeLuRide-005 nonsquamous NSCLC cohort showed an objective response rate of 55.6% (N=36 efficacy evaluable), with data as of May 4, 2026, presented at ASCO 2026.
EIK1003 monotherapy showed a 14.3% objective response rate (7/49), and 24.5% (13/53) in combination with paclitaxel, in Phase 1/2 data as of May 4, 2026.
EIK1006 (AR) IND submission is projected by the end of 2026.
BK Technologies Corporation announced its financial and operating results for the quarter ended June 30, 2026, on August 13, 2026, through an amended press release and an earnings presentation. The filing does not state revenue, profit, or guidance figures, so the results' direction cannot be judged from this document alone.
Results cover the second quarter ended June 30, 2026, announced August 13, 2026.
The amended press release is furnished as Exhibit 99.1.
The earnings presentation is furnished as Exhibit 99.2 and is posted at www.bktechnologies.com.
The filing is signed by CFO Scott A. Malmanger, dated August 13, 2026.
Presidio Production Company reported second-quarter 2026 total revenue of $54.0 million and net income attributable to the company of $14.4 million, or $0.34 per Class A share. The filing presents no prior-period comparison, so the direction of change versus last year or last quarter cannot be determined from it. The company also declared a quarterly dividend of $0.3375 per share and disclosed the July 2026 closing of the Canyon Creek acquisition.
Total revenue was $54.0 million and Adjusted EBITDA was $33.2 million for the quarter ended June 30, 2026.
Quarterly dividend of $0.3375 per share is payable September 14, 2026 to holders of record as of August 31, 2026.
Canyon Creek acquisition closed July 1, 2026, funded with a $55 million draw under the ABS Warehouse Facility and 1,962,240 Class A shares issued to sellers.
Marqeta said its Chief Accounting Officer and principal accounting officer, Sarah Barkema, will resign effective August 21, 2026, and that her departure is not due to any disagreement over financial statements, internal controls, operations, policies or practices. CFO Patti Kangwankij will take over the principal accounting officer role, and the company plans to search for a new Chief Accounting Officer.
Sarah Barkema informed the company of her resignation on August 10, 2026; effective date is August 21, 2026
The company states the departure involves no disagreement on financial statements, internal control, operations, policies or practices
CFO Patti Kangwankij will become principal accounting officer after Barkema leaves
The company intends to search for a new Chief Accounting Officer; no successor is named
Digital Asset Acquisition Corp. and Old Glory Holding Company mutually agreed on August 13, 2026 to terminate their Business Combination Agreement dated January 13, 2026, and abandon the related transactions. Because the deal is terminated, the extraordinary general meeting set for August 14, 2026 has no business to transact and has been indefinitely postponed.
Business Combination Agreement dated January 13, 2026 terminated effective August 13, 2026 under a Mutual Termination and Release Agreement
Section 9.18 of the Business Combination Agreement survives; the filing states no further liability or obligation otherwise applies to either party
Extraordinary general meeting originally set for 10:00 a.m. Eastern Time on August 14, 2026 is indefinitely postponed
Cloudflare issued $2.5 billion of 0% convertible senior notes maturing August 15, 2031, under an indenture dated August 13, 2026. The company reported net proceeds of about $2,462.3 million, of which $259.5 million was used for capped call transactions, with the remainder for general corporate purposes. The notes add a large amount of debt, and conversion into Class A common stock would dilute shareholders unless offset by the capped calls.
Principal of $2.5 billion, 0% interest, maturing August 15, 2031 unless earlier redeemed, repurchased or converted.
Initial conversion price of about $496.94 per share, a 60% premium to the $310.59 closing price on August 10, 2026.
Net proceeds of about $2,462.3 million; $259.5 million used to pay for capped call transactions.
No optional redemption before August 20, 2029, except a cleanup redemption if less than $200.0 million remains outstanding.
Amprius Technologies signed a Second Amendment to its Fremont, California industrial lease with Los Altos Fields, LLC on August 7, 2026. The amendment extends the lease, which had been set to expire June 30, 2027, by 84 months through June 30, 2034, and adds two five-year extension options. The company expects total future lease payments after the amendment to be about $10.5 million.
Lease extended 84 months, from July 1, 2027 through June 30, 2034
Expected total future lease payments after amendment: about $10.5 million
Two five-year extension options, with base rent subject to annual escalation
Agreement dated August 7, 2026; full text filed as Exhibit 10.1
Savers Value Village closed a secondary offering of 23,000,000 shares sold by Ares Private Equity and Opportunistic Credit funds at $10.25 per share. The company received no proceeds from the sale, but it bought 1,021,580 shares from the underwriters using existing cash on hand, a repurchase separate from its existing share repurchase program.
Offering of 23,000,000 shares at $10.25 per share by Ares selling stockholders, agreed August 11, 2026 and completed August 13, 2026
Company received no proceeds from the shares sold by the selling stockholders
Company repurchased 1,021,580 shares from the underwriters, funded from existing cash on hand and not part of its existing share repurchase program
Abacus Global Management's board approved a new stock repurchase program of up to $100 million, starting August 17, 2026 and running until May 6, 2028. The company said it will fund the program from free cash flow, balance sheet transaction proceeds and cash on hand, and that it has repurchased about $80 million of stock under prior programs since December 2023.
Program authorizes up to $100 million of common stock purchases, commencing August 17, 2026
Purchases may be made in the open market or privately, including accelerated share repurchases, block trades and Rule 10b5-1 plans
Program runs until May 6, 2028; about $80 million was repurchased under prior programs since December 2023
Company expects to fund the program from free cash flow, balance sheet transactions and cash on hand
Adagio Medical Holdings furnished an updated corporate presentation for investor, analyst and other meetings, attached as Exhibit 99.1 to a Form 8-K. The filing is a Regulation FD disclosure with no financial results, guidance or transaction terms, so it contains no new reported financial figures.
Updated corporate presentation dated August 13, 2026, made available on the company website and attached as Exhibit 99.1.
Presentation cites FDA approval of vCLAS expected Q4 2026 and of next-generation vCLAS Ultra expected Q1 2028, per company timeline.
Presentation lists cash and cash equivalents of $7.7 million and convertible notes payable of $24.8 million at June 30, 2026.
AbCellera priced an underwritten public offering of 17,435,897 common shares at $9.75 per share, plus pre-funded warrants for up to 3,076,926 shares, with closing expected on or about August 14, 2026. The company estimates net proceeds of about $187.0 million and plans to use them to fund its internal pipeline, including lead clinical program ABCL635, and for working capital. The new shares will add to the existing share count, which dilutes current shareholders' ownership.
Priced 17,435,897 common shares at $9.75 per share, and pre-funded warrants for up to 3,076,926 shares at $9.74999 each
Gross proceeds expected to be about $200.0 million; estimated net proceeds about $187.0 million after underwriting discounts, commissions and offering expenses
Proceeds to fund research, development and clinical advancement of the internal pipeline, including ABCL635, and for working capital and general corporate purposes
Closing expected on or about August 14, 2026; the company and its executive officers and directors agreed to a 60-day restriction on share sales, subject to exceptions
BNY's board elected Vikram Malhotra, a senior partner at McKinsey & Company, as an independent director, effective October 1, 2026. With his addition, the board will have 12 directors, 11 of whom are independent. The filing describes a board seat with customary non-management director compensation and does not report any change to executive officers.
Board elected Malhotra on August 11, 2026, effective October 1, 2026
Board will consist of 12 directors, 11 of them independent
Malhotra has been a senior partner at McKinsey since 1998 and joined the firm in 1986
He will receive non-management director compensation as described in the March 5, 2026 proxy statement
Newmont and Barrick signed a Second Amended and Restated LLC Agreement for the Nevada Gold Mines joint venture, dated August 10, 2026, along with a confidential settlement that resolves all outstanding disputes related to the joint venture. Barrick's Fourmile project and Newmont's Fiberline and Mike projects will be contributed to Nevada JV, and Newmont will pay Barrick $1.95 billion in cash, a large cash outlay for the company. The filing does not state how the transaction affects Newmont's earnings or financial results.
Newmont Member will pay Barrick Member $1.95 billion in cash within 30 days after the Fourmile project is contributed to Nevada JV.
Newmont is deemed to have made a $1.95 billion capital contribution and Barrick is deemed to have made an approximately $3.11 billion capital contribution to Nevada JV.
The settlement resolves all outstanding disputes related to Nevada JV, and Newmont has provided its consent to Barrick's proposed North American IPO.
Upon completion of the contribution of the Projects, Nevada JV will assume all liabilities associated with those Projects.
TWFG, Inc. entered into an Amended and Restated Credit Agreement on August 12, 2026, providing a $125 million revolving credit facility maturing August 12, 2031, with an uncommitted option for an additional $75 million. The filing describes this as a routine refinancing and expansion of existing borrowing capacity, and it adds secured borrowing obligations, covenants and events of default that apply to the Company and its guarantor subsidiaries.
Revolving credit facility of $125 million, including $12.5 million swingline and $12.5 million letter of credit sub-facilities
Uncommitted accordion feature allows the Company to seek an additional $75 million in commitments
Revolving loans mature August 12, 2031; interest at Term SOFR or Daily SOFR plus a margin of 1.75% to 2.75% based on leverage ratio
Facility is secured by substantially all assets of the Borrower and Guarantors and includes debt service coverage and leverage ratio tests
Xylem expanded its Board of Directors from 9 to 10 members and appointed D. Christian Koch to fill the new seat, effective immediately on August 13, 2026. The Board determined Koch is independent, and he also joined the Leadership Development and Compensation Committee and the Nominating and Governance Committee. Koch currently serves as Chairman, President and Chief Executive Officer of Carlisle Companies Incorporated, and the filing states he will receive standard non-employee director compensation, prorated for the current term.
Board size increased from 9 to 10 directors; Koch appointed to fill the vacancy effective August 13, 2026
Koch joins the Leadership Development and Compensation Committee and the Nominating and Governance Committee
Board determined Koch is independent under NYSE listing standards and SEC rules
Koch is Chairman, President and CEO of Carlisle Companies Incorporated; compensation follows the 2026 Proxy Statement filed March 20, 2026, prorated for the current term
GrabAGun Digital Holdings announced that co-founder and CFO Justin Hilty will step down as CFO effective August 14, 2026, and will stay in a transitional role until he retires on September 1, 2026. Jonathan Terry, formerly Vice President, Global Finance at YETI Holdings, takes over as CFO, principal accounting officer and principal financial officer on the same date. The filing states Hilty's decision did not involve any dispute with the company over operations, policies, practices or financial statements.
Justin Hilty resigns as CFO effective August 14, 2026; transitional role until retirement on September 1, 2026
Jonathan Terry appointed CFO effective August 14, 2026; employment began August 10, 2026
Terry's base salary is $400,000, with a target bonus of 60% of salary and a maximum of 120%
Terry received $300,000 in restricted stock units vesting in thirds on August 10, 2027, 2028 and 2029
On August 13, 2026, Illumina entered into a new $1,000 million senior unsecured five-year revolving credit facility with Bank of America, N.A. as administrative agent, which replaces the Existing Credit Agreement dated January 4, 2023, that was terminated the same day. As of the filing date, no borrowings were outstanding, and the facility matures on August 13, 2031, subject to extension options.
Facility size: $1,000 million senior unsecured five-year revolving credit, with a $50 million swingline sublimit and a $75 million letter of credit sublimit
Option to add up to $500 million in term loans or commitment increases, subject to lender consent
No borrowings outstanding as of the filing date; maturity August 13, 2031
Existing Credit Agreement dated January 4, 2023 was terminated as of August 13, 2026
Addus HomeCare said President and Chief Operating Officer Heather Dixon left the company on August 7, 2026. The company appointed W. Bradley Bickham, its former president and COO, as interim COO on the same day, under an employment agreement that runs through July 31, 2027.
Heather Dixon, President and Chief Operating Officer, left the company on August 7, 2026.
W. Bradley Bickham, age 63, was appointed interim Chief Operating Officer on August 7, 2026.
Bickham's employment agreement, dated August 10, 2026, sets an annualized base salary of $622,000 plus fixed bonuses.
Bickham previously served as President and COO from March 2021 to September 2025 and as Advisor to the CEO from September 2025.
BOA Acquisition Corp. II said holders of its units may separately trade the Class A ordinary shares and rights starting August 14, 2026. Unseparated units will keep trading under THEOU, while the separated shares and rights will trade as THEO and THEOR on Nasdaq. This is a routine administrative step for a blank-check company and does not change its business or financial results.
Separate trading of Class A ordinary shares and rights begins August 14, 2026.
Shares will trade on Nasdaq as THEO and rights as THEOR; unseparated units continue as THEOU.
Unit holders must have their brokers contact transfer agent Odyssey Transfer and Trust Company, LLC to separate units.
The registration statement on Form S-1 was declared effective by the SEC on August 3, 2026.
FS KKR Capital Corp. said it will post investor presentations on its website after the market close on August 13, 2026, under the Events & Presentations page. The filing contains no financial results, guidance, or new financial figures, so it offers shareholders no new measurable information beyond the posting itself.
Investor presentations to be posted on the company website after market close on August 13, 2026
Presentations are listed under the Events & Presentations page in the For Investors section
Filing is a Regulation FD disclosure; the company states it does not update the presentations except as securities laws require
WidePoint Corporation disclosed that Executive Vice President and Chief Revenue Officer Jason Holloway tendered his resignation on August 7, 2026, effective December 31, 2026. The company said the departure is for personal and family reasons and not due to any disagreement with the company.
Jason Holloway resigned as Executive Vice President and Chief Revenue Officer, tendered August 7, 2026.
Resignation is effective December 31, 2026.
Company states the departure is for personal and family reasons and involved no disagreement with the company.
The company thanked Mr. Holloway for his significant contributions.
Ames National Corporation declared a cash dividend of $0.24 per common share on August 12, 2026, as disclosed in an 8-K filed August 13, 2026. The dividend is payable September 15, 2026, to shareholders of record at the close of business on September 1, 2026, so holders on that record date will receive the payment.
Cash dividend of $0.24 per common share declared August 12, 2026
Record date: close of business September 1, 2026
Payment date: September 15, 2026
Company trades on the NASDAQ Capital Market under ticker ATLO
HireQuest, Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.06 per share. The dividend is payable September 15, 2026, to shareholders of record on September 1, 2026, and the filing does not include financial results or guidance.
Quarterly cash dividend of $0.06 per share declared by the Board of Directors
Payment date is September 15, 2026
Record date is September 1, 2026
Filing is a Regulation FD disclosure; the press release was furnished as Exhibit 99.1 and does not include financial results
ONE Gas, Inc. completed an underwritten public offering of $375 million of 5.45% senior notes due 2036 on August 13, 2026, after entering the underwriting agreement on August 11. The company expects to use the net proceeds to repay its $250 million unsecured term loan, amounts outstanding under its commercial paper program, and for general corporate purposes. The filing adds new long-term debt but does not report earnings or guidance changes.
Issued $375 million aggregate principal of 5.45% Senior Notes due 2036, underwritten by BofA Securities, RBC Capital Markets and Truist Securities
Underwriting agreement dated August 11, 2026; offering completed August 13, 2026
Net proceeds expected to repay a $250 million unsecured term loan and commercial paper, plus general corporate purposes
Notes issued under a Base Indenture with U.S. Bank Trust Company, National Association, as trustee
Omeros Corporation's board increased its size to nine directors on August 12, 2026, and appointed Joseph Schocken as a director effective immediately. The board also named him to the Audit Committee, and he received a stock option for 30,000 shares under the company's non-employee director pay policy.
Joseph Schocken, 79, appointed director effective August 12, 2026; board expanded to nine directors
Initial term runs until the 2027 annual meeting of shareholders, or earlier resignation or removal
Appointed to the Audit Committee; granted a stock option for 30,000 shares of common stock
NANO Nuclear reported third quarter fiscal 2026 results and a business update, saying it had about $580 million in cash, cash equivalents and short-term investments at June 30, 2026. The filing says the U.S. Nuclear Regulatory Commission docketed the construction permit application for its KRONOS MMR reactor at the University of Illinois, and that the company completed its acquisition of Secured Transportation Systems.
NRC docketed the KRONOS MMR construction permit application in May 2026; the NRC expects to complete its safety evaluation in the third quarter of 2027.
Cash, cash equivalents and short-term investments were about $580 million at June 30, 2026.
$18.7 million was used in operating activities in the nine months ended June 30, 2026, about $4.0 million more than a year earlier.
STS generated audited revenue of about $7.1 million and net income of about $1.3 million in the twelve months ended December 31, 2025.
Parker-Hannifin completed its acquisition of Filtration Group on August 13, 2026, for a cash purchase price of $9.25 billion, subject to a net working capital adjustment. The company borrowed $5.25 billion under a 364-Day delayed draw term loan and $2.50 billion under a Three-Year delayed draw term loan to help pay the purchase price and related fees and expenses.
Cash purchase price of $9.25 billion on a cash-free, debt-free basis, subject to a net working capital adjustment
Merger completed August 13, 2026, under the Merger Agreement signed November 10, 2025
Borrowed $5.25 billion under the 364-Day Credit Facility and $2.50 billion under the Three-Year Credit Facility on August 13, 2026
Credit agreements dated December 10, 2025, with Barclays Bank PLC and KeyBank National Association as administrative agents
Entergy Louisiana, LLC sold $500 million of 5.50% Collateral Trust Mortgage Bonds due 2036 and $500 million of 6.20% bonds due 2056, with the sale closing on August 13, 2026. The bonds were issued under an automatic shelf registration, and the filing is a routine debt financing that adds $1 billion of long-term debt for the company.
2036 Bonds: $500 million aggregate principal, 5.50% coupon, due September 15, 2036
2056 Bonds: $500 million aggregate principal, 6.20% coupon, due September 15, 2056
Sale closed on August 13, 2026, under an Underwriting Agreement and a Form S-3 shelf registration
First National Corporation's board declared a quarterly cash dividend of $0.17 per common share on August 12, 2026. The dividend is payable September 11, 2026 to shareholders of record as of August 28, 2026.
Quarterly cash dividend: $0.17 per common share
Declared by the board on August 12, 2026
Payable September 11, 2026 to holders of record as of August 28, 2026
On August 12, 2026, Epsilon Energy issued its Q3 and full-year 2026 production and capital guidance, attached as Exhibit 99.1. The guidance sets Q3 total production at 3,270 to 3,510 MMcfe and full-year production at 13,740 to 14,280 MMcfe, with total capital of $24.0 million to $28.5 million for Q3 and $42.0 million to $47.0 million for the full year. The filing does not compare these ranges with earlier guidance or report actual results, so shareholders can use them as a forward operating outlook.
Q3 2026 total production guided at 3,270 to 3,510 MMcfe; oil at 155 to 165 MBbl.
FY 2026 total production guided at 13,740 to 14,280 MMcfe; oil at 640 to 670 MBbl.
Total capital guided at $24.0 million to $28.5 million for Q3 and $42.0 million to $47.0 million for FY 2026.
Second-half 2026 program includes 3 gross (2.1 net) operated Parkman wells in the Powder River Basin.
Universal Health Services agreed on August 11, 2026 to sell $1.1 billion of senior secured notes through underwriters led by J.P. Morgan, BofA Securities, Truist, U.S. Bancorp and Wells Fargo. The filing says the company's revolving credit facility borrowings will be repaid from the proceeds, and it notes J.P. Morgan is also the company's financial advisor on its proposed acquisition of Talkspace, Inc.
Two tranches: $600 million of 5.500% notes due 2031 and $500 million of 6.000% notes due 2036
Notes are guaranteed on a senior secured basis by the company's subsidiary guarantors and sold under an S-3 shelf registration
Proceeds will be used in part to repay outstanding borrowings under the revolving credit facility
Underwriting agreement dated August 11, 2026; prospectus supplement filed with the SEC on August 13, 2026
Sonida Senior Living entered into a $380.0 million senior secured term loan with Ally Bank on August 7, 2026, which amends and restates its existing Ally term loan. The new loan carries a 5-year maturity, a variable rate of one-month SOFR plus 1.85%, and interest-only payments during the initial term, and it covers 28 communities, including 9 acquired in March 2026 through the merger with CNL Healthcare Properties.
Total facility of $380.0 million with a closing fee of 0.75%, or $2.85 million
Initial advance of $372.5 million on closing date; an additional $7.5 million draw is available subject to debt yield and debt service coverage requirements
Five-year maturity with two 12-month extension options; variable rate of one-month SOFR plus 1.85%
As of August 7, 2026, $122.0 million was outstanding under the existing Ally loan, which had a maturity date of August 7, 2028
Monro's Board of Directors declared a quarterly cash dividend of $.28 per share on August 11, 2026. The same day, shareholders elected eight directors, approved executive pay on an advisory basis, and ratified PricewaterhouseCoopers as the independent accounting firm for the fiscal year ending March 27, 2027.
Quarterly cash dividend of $.28 per share, payable September 8, 2026 to shareholders of record as of August 25, 2026
Annual Meeting held August 11, 2026, with about 88.72% of outstanding shares represented
PricewaterhouseCoopers, LLP ratified with 21,678,339 votes for and 900,051 against
Sprinklr expanded its board from seven to eight directors by appointing Jordi Ribas, Ph.D., President of Search & AI at Microsoft, effective August 17, 2026. The filing describes his compensation as a non-employee director, which includes equity awards valued at $200,000 each and cash retainers, and notes that director Eileen Schloss was removed from the Strategy Committee to make room for him.
Board size increased from seven to eight directors; Ribas appointed as a Class II director with a term expiring at the 2029 Annual Meeting
Initial and annual RSU awards valued at $200,000 each, plus a $40,000 base cash retainer and additional committee retainers
Ribas joins the Nominating and Corporate Governance Committee and Strategy Committee; Eileen Schloss removed from the Strategy Committee effective August 17, 2026
Wabash National signed a sixth amendment to its credit agreement on August 12, 2026, with Wells Fargo Capital Finance as administrative agent. The amended facility provides a $300 million revolving credit line, with an option to add up to $175 million in commitments subject to conditions. The filing sets out borrowing terms, a $40 million availability block, and minimum liquidity and fixed charge coverage requirements that shareholders may want to track.
Revolving credit facility of $300 million, with an option to increase commitments by up to an additional $175 million, subject to conditions
Facility matures on the earliest of August 12, 2031, or 91 days before the 4.50% Senior Notes due 2028 or the 4.00% Convertible Senior Notes due 2032 mature
Company must keep minimum liquidity of $90 million before the Financial Covenant Conversion Date, and a $40 million availability block applies until that date
Borrowings bear interest at term SOFR plus 1.50% to 2.00%, or a base rate plus 0.50% to 1.00%, with a monthly unused line fee of 0.20%
Rockwell Medical furnished an updated corporate presentation to investors on August 13, 2026, as Exhibit 99.1 to a Form 8-K. The filing contains no financial results, guidance, or other quantitative figures, and the company states the information is not deemed filed under Section 18 of the Exchange Act.
Updated corporate presentation made available on August 13, 2026, furnished as Exhibit 99.1
Filed under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits)
Filing signed by CEO Mark Strobeck; signature block is dated May 7, 2026, which differs from the August 13, 2026 filing date
Olema Pharmaceuticals announced on August 13, 2026 that Jason O'Byrne has been appointed Chief Financial Officer, principal financial officer and principal accounting officer, effective August 11, 2026. He most recently served as Executive Vice President and Chief Financial Officer of Vir Biotechnology from October 2024 to August 2026. The filing sets his pay, including a $545,000 initial base salary and an option for 650,000 shares that is subject to Board approval.
Initial annualized base salary of $545,000 and an annual bonus target of 45% of base salary
Sign-on bonuses of $250,000 (within 30 days of the effective date) and $100,000 (within 30 days after the first anniversary), subject to service-based repayment
Option for 650,000 common shares under the 2022 Inducement Plan, vesting over four years, subject to Board approval
Severance includes 12 months of base salary; double-trigger protection applies if termination occurs within 3 months before or 18 months after a Change in Control
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.